# Demonstrating the Diagnostic Power of an Electronic Nose: Study on Exhaled Air Samples

> **NCT03721042** · NA · TERMINATED · sponsor: **Nouvelle Clinique Bonnefon** · enrollment: 68 (actual)

## Conditions studied

- Alzheimer Disease
- Gastric Cancer
- Urologic Cancer
- Pneumological Cancer

## Interventions

- **DEVICE:** olfactory measuring device

## Key facts

- **NCT ID:** NCT03721042
- **Lead sponsor:** Nouvelle Clinique Bonnefon
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-10-11
- **Primary completion:** 2019-11-05
- **Final completion:** 2020-10-01
- **Target enrollment:** 68 (ACTUAL)
- **Why stopped:** no PI to continue the study
- **Last updated:** 2022-04-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03721042

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03721042, "Demonstrating the Diagnostic Power of an Electronic Nose: Study on Exhaled Air Samples". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT03721042. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*